AMNIVUZ
LIVE

Serial Number

99161396

Owner

Amgen Inc.

Attorney

Elsa D. Lemoine

Filing Date

Apr 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AMNIVUZ Trademark

Serial Number: 99161396

AMNIVUZ is a trademark filed by Amgen Inc. on April 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Amgen Inc. (18 trademarks)

One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Entity Type: 03

Trademark Details

Filing Date

April 29, 2025

Registration Date

Not Registered

Published for Opposition

December 23, 2025

Goods & Services

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 17, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 25, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 25, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 29, 2025 MAFR
NEW APPLICATION ENTERED
Apr 29, 2025 NWAP